ACI Forum on Pharma & Biotech Patent Litigation USA 2025

Axinn partner Aziz Burgy and counsel Rebecca Clegg will speak at American Conference Institute's Forum on Pharma & Biotech Patent Litigation USA, being held October 14-15 in New York. 

On October 14, Aziz will speak on "Hatch-Waxman Lightning Round: Examining New Trends in Paragraph IV Litigation."  Panelists will discuss: 

• Examining Paragraph IV litigation trends around patent thickets
• Understanding how new interpretations of the safe harbor will impact your litigation strategies
• Examining prior art exceptions to the on-sale bar
• Determining litigation targets; and
• Deconstructing inducement of infringement and skinny labeling as a strategy and a threat. 
  

On October 15, Rebecca will speak on "The Second Generation of Cellect: How Obviousness-Type Double Patenting Has Changed the Game." Panelists will discuss: 

• How patent litigation has been impacted since the Cellect decision was handed down; 
• Developing effective litigation strategies in a post-Cellect landscape; 
• Taking down PTAs with Cellect in your toolkit; and 
• Considering the patent rights of CRISPR technology.